ALFA FinderNSE filing, NSE: JUBLINGREA. Summary written from the filing by ALFA Finder's alert engine.
Jubilant Ingrevia Ltd: key numbers
- Share price
- ₹607.00
- Market cap
- ₹9,668 Cr
- Revenue (annual)
- ₹4,388 Cr
- Net profit (annual)
- ₹277.9 Cr
- P/E (TTM)
- 27.6×Sector 35.5×
- Promoter holding
- 45.22%+0.00% QoQ
- FII holding
- 6.93%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jubilant Ingrevia Ltd
All →Jubilant Ingrevia Merger & Restructuring
Jubilant Ingrevia updated on a restructuring share subscription and purchase agreement closing in two tranches. First tranche is due by November 2026, second by September 2027.
- Execution
- First tranche by November 2026; second tranche by September 2027
Jubilant Ingrevia Acquisition
Jubilant Ingrevia's subsidiary JAEL signed the SSPA for a 40% stake in Zettaone, with an option to reach 51%. The deal enters electronics design and manufacturing services.
Jubilant Ingrevia Other Announcement
Jubilant Ingrevia Limited filed its quarterly shareholding pattern for the period ended 30 September 2026. The filing records the holdings of promoters, public shareholders and other categories.
Jubilant Ingrevia Employee Stock Options
Jubilant Ingrevia Employees Welfare Trust bought 45,000 shares on NSE for ₹2.49 Crore under its ESOP scheme. Post-trade holding rose to 0.98% of total equity.
- Value
- ₹2.49 Cr
Jubilant Ingrevia Earnings Call Transcript: Key Takeaways
Strong Q2 performance driven by volume growth across specialty chemicals and nutrition despite price softness in China.
Jubilant Ingrevia Management Change
Jubilant Ingrevia's Sr. Vice President & Head HR, Ms. Vinita Koul, resigned effective November 6, 2026. The departure is to pursue other interests.
Other results update announcements
All →Glottis Results Update
Glottis reported Q2 FY27 revenue of ₹2,765 million, up 28.8% YoY, but EBITDA fell to ₹34 million. PAT was a loss of ₹0.2 million for the quarter.
Lotus Eye Hospital and Institute Results Update
Lotus Eye Hospital reported Q2 FY27 revenue of ₹17.72 crore, up 36%, with net profit of ₹43.95 lakh. Half-year net profit rose 59% to ₹1.05 crore.
Orient Green Power Company Results Update
Orient Green Power reported H1 FY27 net profit of ₹106 Cr at 76% EBITDA margin. It commissioned 17.6 MW solar capacity during the quarter.
- solar capacity added
- 17.6 MW
IC Electricals Company Results Update
IC Electricals reported H1 FY27 standalone revenue of Rs 73.22 Crore, up 32%, and PAT of Rs 7.56 Crore, up 114%. Order book reached Rs 231 Crore.
- Order book
- ₹231.1 Cr
Sical Logistics Results Update
Sical Logistics issued a press release on its unaudited Q2 and H1 FY27 results, with consolidated revenue up 17.4% and 27.1% YoY. Q2 EBITDA fell to Rs 96 million from Rs 181 million.
Intense Technologies Results Update
Intense Technologies issued a press release on H1 FY27 results, showing net profit of ₹222.70 lakhs. Profit declined from ₹442.32 lakhs in the prior-year half.